🇧🇷 Parsabiv in Brazil

Parsabiv (ETELCALCETIDE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Parsabiv in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in Brazil

Frequently asked questions

Is Parsabiv approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Parsabiv in Brazil?

Kai Pharms Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.